CD86+/CD206+ tumor-associated macrophages predict prognosis of patients with intrahepatic cholangiocarcinoma
Background As the main cellular ingredients of tumor microenvironment, tumor-associated macrophages (TAMs) play a vital role in tumor development and progression. Recent studies have suggested that TAMs are sensitive and specific prognostic factors in numerous cancers. The primary purpose of this st...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
PeerJ Inc.
2020-01-01
|
| Series: | PeerJ |
| Subjects: | |
| Online Access: | https://peerj.com/articles/8458.pdf |
| _version_ | 1797417797499748352 |
|---|---|
| author | Dalong Sun Tiancheng Luo Pingping Dong Ningping Zhang Jing Chen Shuncai Zhang Longzi Liu Ling Dong Si Zhang |
| author_facet | Dalong Sun Tiancheng Luo Pingping Dong Ningping Zhang Jing Chen Shuncai Zhang Longzi Liu Ling Dong Si Zhang |
| author_sort | Dalong Sun |
| collection | DOAJ |
| description | Background As the main cellular ingredients of tumor microenvironment, tumor-associated macrophages (TAMs) play a vital role in tumor development and progression. Recent studies have suggested that TAMs are sensitive and specific prognostic factors in numerous cancers. The primary purpose of this study is to determine the prognostic significance of TAMs in intrahepatic cholangiocarcinoma (ICC). Methods Immunohistochemical staining of CD68, CD86 and CD206 were performed in tissue microarrays containing 322 patients, who underwent surgical resection and were pathologically diagnosed with ICC. The prognostic value of CD68, CD86 and CD206 were evaluated by Kaplan–Meier analysis (log-rank test) and nomogram models. Results We demonstrated that the CD86+/CD206+ TAMs model was an independent prognostic index for ICC patients. Patients with low CD86+ TAMs and high CD206+ TAMs infiltration had a markedly worse prognosis and increased risk of post-operative recurrence when compared to high CD86+ TAMs and low CD206+ TAMs intratumoral infiltration. Furthermore, subgroup analysis indicated that the CD86+/CD206+ TAMs model predicted prognosis of ICC patients more powerfully than single macrophage immunomarker. Interestingly, the CD86+/CD206+ TAMs model could further distinguish prognosis of CA-199 negative ICC patients, who were generally presumed to have a more favorable outcome. In order to further perfect the prognostic value of the CD86+/CD206+ TAMs model, we constructed and validated a postoperative nomogram to predict overall survival and recurrence-free survival time in ICC patients. Conclusions These findings indicate that the CD86+/CD206+ TAMs model possess potential value as a novel prognostic indicator for ICC patients. |
| first_indexed | 2024-03-09T06:23:52Z |
| format | Article |
| id | doaj.art-709acd7115144ee7b76b02ed5a19f5fe |
| institution | Directory Open Access Journal |
| issn | 2167-8359 |
| language | English |
| last_indexed | 2024-03-09T06:23:52Z |
| publishDate | 2020-01-01 |
| publisher | PeerJ Inc. |
| record_format | Article |
| series | PeerJ |
| spelling | doaj.art-709acd7115144ee7b76b02ed5a19f5fe2023-12-03T11:29:44ZengPeerJ Inc.PeerJ2167-83592020-01-018e845810.7717/peerj.8458CD86+/CD206+ tumor-associated macrophages predict prognosis of patients with intrahepatic cholangiocarcinomaDalong Sun0Tiancheng Luo1Pingping Dong2Ningping Zhang3Jing Chen4Shuncai Zhang5Longzi Liu6Ling Dong7Si Zhang8Department of Gastroenterology and Hepatology, Zhongshan Hospital, Fudan University, Shanghai, ChinaDepartment of Gastroenterology and Hepatology, Zhongshan Hospital, Fudan University, Shanghai, ChinaDepartment of Surgery, Faculty of Medicine, The University of Hong Kong, Hong Kong, ChinaDepartment of Gastroenterology and Hepatology, Zhongshan Hospital, Fudan University, Shanghai, ChinaDepartment of Neurology, Zhongshan Hospital, Fudan University, Shanghai, ChinaDepartment of Gastroenterology and Hepatology, Zhongshan Hospital, Fudan University, Shanghai, ChinaDepartment of General Surgery, The First Affliated Hospital of Nanchang University, Nanchang, Jiangxi, ChinaDepartment of Gastroenterology and Hepatology, Zhongshan Hospital, Fudan University, Shanghai, ChinaNHC Key Laboratory of Glycoconjugate Research, Department of Biochemistry and Molecular Biology, Shanghai Medical College, Fudan University, Shanghai, ChinaBackground As the main cellular ingredients of tumor microenvironment, tumor-associated macrophages (TAMs) play a vital role in tumor development and progression. Recent studies have suggested that TAMs are sensitive and specific prognostic factors in numerous cancers. The primary purpose of this study is to determine the prognostic significance of TAMs in intrahepatic cholangiocarcinoma (ICC). Methods Immunohistochemical staining of CD68, CD86 and CD206 were performed in tissue microarrays containing 322 patients, who underwent surgical resection and were pathologically diagnosed with ICC. The prognostic value of CD68, CD86 and CD206 were evaluated by Kaplan–Meier analysis (log-rank test) and nomogram models. Results We demonstrated that the CD86+/CD206+ TAMs model was an independent prognostic index for ICC patients. Patients with low CD86+ TAMs and high CD206+ TAMs infiltration had a markedly worse prognosis and increased risk of post-operative recurrence when compared to high CD86+ TAMs and low CD206+ TAMs intratumoral infiltration. Furthermore, subgroup analysis indicated that the CD86+/CD206+ TAMs model predicted prognosis of ICC patients more powerfully than single macrophage immunomarker. Interestingly, the CD86+/CD206+ TAMs model could further distinguish prognosis of CA-199 negative ICC patients, who were generally presumed to have a more favorable outcome. In order to further perfect the prognostic value of the CD86+/CD206+ TAMs model, we constructed and validated a postoperative nomogram to predict overall survival and recurrence-free survival time in ICC patients. Conclusions These findings indicate that the CD86+/CD206+ TAMs model possess potential value as a novel prognostic indicator for ICC patients.https://peerj.com/articles/8458.pdfIntrahepatic cholangiocarcinomaTumor-associated macrophagesCA-199PrognosisCD206CD86 |
| spellingShingle | Dalong Sun Tiancheng Luo Pingping Dong Ningping Zhang Jing Chen Shuncai Zhang Longzi Liu Ling Dong Si Zhang CD86+/CD206+ tumor-associated macrophages predict prognosis of patients with intrahepatic cholangiocarcinoma PeerJ Intrahepatic cholangiocarcinoma Tumor-associated macrophages CA-199 Prognosis CD206 CD86 |
| title | CD86+/CD206+ tumor-associated macrophages predict prognosis of patients with intrahepatic cholangiocarcinoma |
| title_full | CD86+/CD206+ tumor-associated macrophages predict prognosis of patients with intrahepatic cholangiocarcinoma |
| title_fullStr | CD86+/CD206+ tumor-associated macrophages predict prognosis of patients with intrahepatic cholangiocarcinoma |
| title_full_unstemmed | CD86+/CD206+ tumor-associated macrophages predict prognosis of patients with intrahepatic cholangiocarcinoma |
| title_short | CD86+/CD206+ tumor-associated macrophages predict prognosis of patients with intrahepatic cholangiocarcinoma |
| title_sort | cd86 cd206 tumor associated macrophages predict prognosis of patients with intrahepatic cholangiocarcinoma |
| topic | Intrahepatic cholangiocarcinoma Tumor-associated macrophages CA-199 Prognosis CD206 CD86 |
| url | https://peerj.com/articles/8458.pdf |
| work_keys_str_mv | AT dalongsun cd86cd206tumorassociatedmacrophagespredictprognosisofpatientswithintrahepaticcholangiocarcinoma AT tianchengluo cd86cd206tumorassociatedmacrophagespredictprognosisofpatientswithintrahepaticcholangiocarcinoma AT pingpingdong cd86cd206tumorassociatedmacrophagespredictprognosisofpatientswithintrahepaticcholangiocarcinoma AT ningpingzhang cd86cd206tumorassociatedmacrophagespredictprognosisofpatientswithintrahepaticcholangiocarcinoma AT jingchen cd86cd206tumorassociatedmacrophagespredictprognosisofpatientswithintrahepaticcholangiocarcinoma AT shuncaizhang cd86cd206tumorassociatedmacrophagespredictprognosisofpatientswithintrahepaticcholangiocarcinoma AT longziliu cd86cd206tumorassociatedmacrophagespredictprognosisofpatientswithintrahepaticcholangiocarcinoma AT lingdong cd86cd206tumorassociatedmacrophagespredictprognosisofpatientswithintrahepaticcholangiocarcinoma AT sizhang cd86cd206tumorassociatedmacrophagespredictprognosisofpatientswithintrahepaticcholangiocarcinoma |